Alembic Pharma gets USFDA nod to Diltiazem Hydrochloride ER Capsules to treat hypertension MD Bureau22 Oct 2024 2:20 PM ISTMumbai: Drug maker Alembic Pharmaceuticals Ltd has recently announced that it has received final approval from the United States Food and Drug...
Sanofi's Opella sale faces political backlash amid fears of drug shortages MD Bureau22 Oct 2024 10:15 AM ISTParis: French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund...
Sanofi, CD&R in exclusive talks over sale of USD17 billion Opella MD Bureau22 Oct 2024 10:00 AM ISTSanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024
India's Bioeconomy surges to USD 150 billion, but innovation gaps remain, says BIRAC MD MD Bureau22 Oct 2024 9:30 AM ISTBIRAC MD highlighted India's significant contributions to global healthcare, with 40 percent of the world's generic drugs being supplied by Indian...
Lupin names Claus Jepsen as President, Global Specialty MD Bureau21 Oct 2024 6:22 PM ISTClaus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.
Vaccine Maker to Film Maker: Serum's Adar Poonawala to invest in Karan Johar's production company MD Bureau21 Oct 2024 3:31 PM ISTSerene Productions has entered into a binding agreement to invest Rs 1,000 crore in production house Dharma Productions and Dharmatic Entertainment...
Indian pharma firms lag behind global peers in RnD, Patents, Publications, reveals report MD Bureau21 Oct 2024 2:15 PM ISTThe largest disparity was observed in the number of publications per billion USD revenue, with global firms producing 8.4 times more publications than...
Allergan's Botox Cosmetic now approved for treating platysma bands MD Bureau21 Oct 2024 2:00 PM ISTBotox Cosmetic is the first and only product with four aesthetic indication areas: forehead lines, frown lines, crow's feet lines, and now platysma...
Sanofi closes deal for consumer health unit Opella: Report MD Bureau21 Oct 2024 1:18 PM ISTThe breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the country
Merck eyes more acquisitions for life science after USD 600M Mirus Bio deal MD Bureau20 Oct 2024 10:15 AM ISTMerck also said it will intensify the in licensing of drug candidates in its Healthcare division.
CVS Health CEO steps down amid financial challenges MD Bureau20 Oct 2024 9:45 AM ISTCVS cut its financial expectations for the third time in August with all major pharmacy chains attempting to navigate a drastically changed landscape
Kezar to terminate mid-stage trial for Lupus treatment MD Bureau20 Oct 2024 9:30 AM ISTThe regulator's decision came after the company paused the study in September to review safety data following the deaths of four patients.
